James Edward Doyle insider trades: Exact Sciences (EXAS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | EXAS | ↓ Sell10b5-1 | 2,000 | $60.00 | $120K | Direct | Oct 10, 2025 (1d) |
| Aug 13, 2025 | EXAS | ↓ Sell10b5-1 | 1,485 | $42.02 | $62K | Direct | Aug 14, 2025 (1d) |
| Mar 1, 2024 | EXAS | ↓ Sell10b5-1 | 2,000 | $57.50 | $115K | Direct | Mar 4, 2024 (3d) |
| Jul 27, 2023 | EXAS | ↓ Sell10b5-1 | 2,000 | $97.42 | $195K | Direct | Jul 28, 2023 (1d) |
| Jun 9, 2023 | EXAS | ↓ Sell10b5-1 | 1,402 | $90.51 | $127K | Direct | Jun 12, 2023 (3d) |
| May 26, 2023 | EXAS | ↓ Sell10b5-1 | 2,000 | $80.62 | $161K | Direct | May 31, 2023 (5d) |
| Jul 30, 2021 | EXAS | ↓ Sell | 2,640 | $111.17 | $293K | Direct | Aug 2, 2021 (3d) |
| Feb 26, 2021 | EXAS | ↓ Sell10b5-1 | 2,000 | $130.11 | $260K | Direct | Mar 2, 2021 (4d) |
| Jul 31, 2020 | EXAS | ↓ Sell10b5-1 | 2,539 | $94.00 | $239K | Direct | Aug 4, 2020 (4d) |
| Feb 28, 2020 | EXAS | ↓ Sell10b5-1 | 2,000 | $77.54 | $155K | Direct | Mar 3, 2020 (4d) |
| Jul 31, 2019 | EXAS | ↓ Sell10b5-1 | 2,808 | $117.93 | $331K | Direct | Aug 2, 2019 (2d) |
| Feb 28, 2019 | EXAS | ↓ Sell10b5-1 | 2,000 | $96.00 | $192K | Direct | Mar 1, 2019 (1d) |
| Jul 30, 2018 | EXAS | ↓ Sell10b5-1 | 1,318 | $58.86 | $78K | Direct | Aug 1, 2018 (2d) |
| Apr 10, 2018 | EXAS | ↓ Sell10b5-1 | 3,098 | $40.97 | $127K | Direct | Apr 12, 2018 (2d) |
| Mar 8, 2016 | EXAS | ↑ Buy | 5,000 | $6.43 | $32K | Direct | Mar 8, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EXAS insiders
Open-market trades in the last 12 months
About James Edward Doyle's insider trades
James Edward Doyle is an insider at Exact Sciences (EXAS). Since Mar 8, 2016, James has reported 1 open-market purchase worth $32K and 14 sales worth $2.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
13 sales (88% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.